These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17022620)

  • 21. Current approach to hemochromatosis.
    Brissot P; Troadec MB; Bardou-Jacquet E; Le Lan C; Jouanolle AM; Deugnier Y; Loréal O
    Blood Rev; 2008 Jul; 22(4):195-210. PubMed ID: 18430498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging role of the liver in iron metabolism.
    Sharma N; Butterworth J; Cooper BT; Tselepis C; Iqbal TH
    Am J Gastroenterol; 2005 Jan; 100(1):201-6. PubMed ID: 15654801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective role of calreticulin in HFE hemochromatosis.
    Pinto JP; Ramos P; de Almeida SF; Oliveira S; Breda L; Michalak M; Porto G; Rivella S; de Sousa M
    Free Radic Biol Med; 2008 Jan; 44(1):99-108. PubMed ID: 18045552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
    Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P
    Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemochromatosis: an endocrine liver disease.
    Pietrangelo A
    Hepatology; 2007 Oct; 46(4):1291-301. PubMed ID: 17886335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypersiderosis and dissiderosis in the context of data on hemochromatosis microelementosis].
    Smirnov OA
    Arkh Patol; 2008; 70(3):3-8. PubMed ID: 18727423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex, drugs, and "heavy metal": does diet also matter in the clinical expression of hereditary hemochromatosis?
    McCune CA
    Mayo Clin Proc; 2008 May; 83(5):526-8. PubMed ID: 18452680
    [No Abstract]   [Full Text] [Related]  

  • 28. [Contribution of molecular genetics in understanding iron metabolism].
    Yamaguchi-Iwai Y
    Seikagaku; 2004 May; 76(5):441-4. PubMed ID: 15212232
    [No Abstract]   [Full Text] [Related]  

  • 29. Reconstitution of normal hepcidin expression in Hfe-deficient mice after liver transplantation: a new role of HFE in Kupffer cells?
    De Domenico I; Kushner JP
    Gastroenterology; 2010 Jul; 139(1):25-7. PubMed ID: 20639083
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele.
    Biasiotto G; Roetto A; Daraio F; Polotti A; Gerardi GM; Girelli D; Cremonesi L; Arosio P; Camaschella C
    Blood Cells Mol Dis; 2004; 33(3):338-43. PubMed ID: 15528154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.
    Nicolas G; Bennoun M; Devaux I; Beaumont C; Grandchamp B; Kahn A; Vaulont S
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8780-5. PubMed ID: 11447267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation.
    D'Alessio F; Hentze MW; Muckenthaler MU
    J Hepatol; 2012 Nov; 57(5):1052-60. PubMed ID: 22728873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Regulation of body iron homeostasis by hepcidin].
    Lipiński P; Starzyński RR
    Postepy Hig Med Dosw (Online); 2004 Mar; 58():65-73. PubMed ID: 15069380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6.
    Truksa J; Peng H; Lee P; Beutler E
    Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10289-10293. PubMed ID: 16801541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-HFE hemochromatosis.
    Pietrangelo A
    Hepatology; 2004 Jan; 39(1):21-9. PubMed ID: 14752817
    [No Abstract]   [Full Text] [Related]  

  • 37. Parenteral vs. oral iron: influence on hepcidin signaling pathways through analysis of Hfe/Tfr2-null mice.
    McDonald CJ; Wallace DF; Ostini L; Subramaniam VN
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(2):G132-9. PubMed ID: 24284962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-HFE-related hemochromatosis: the role of genetic factors.
    Castiella A; Zapata E; Otazua P; Zubiaurre L; Fernandez J
    Hepatology; 2010 Apr; 51(4):1473-4; author reply 1474. PubMed ID: 20373380
    [No Abstract]   [Full Text] [Related]  

  • 39. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.
    Wallace DF; Summerville L; Crampton EM; Frazer DM; Anderson GJ; Subramaniam VN
    Hepatology; 2009 Dec; 50(6):1992-2000. PubMed ID: 19824072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter by Sullivan regarding article, "HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: the hemochromatosis and iron overload screening study".
    Sullivan JL
    Circ Cardiovasc Genet; 2009 Jun; 2(3):e1. PubMed ID: 20031587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.